Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-AXL, HuMax-AXL-ADC Vector   (CAT#: GTVCR-WQ1449MR)

This product GTVCR-WQ1449MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting AXL. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_001278599.2
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 558
UniProt ID M0R0W6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-AXL, HuMax-AXL-ADC Vector (GTVCR-WQ1449MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1176MR IVTScrip™ pT7-VEE-mRNA-Anti-CSF3R, F-627 Vector Vector F-627
GTVCR-WQ1483MR IVTScrip™ pT7-VEE-mRNA-Anti-MS4A1, IDEC-C2B8 Vector Vector IDEC-C2B8
GTVCR-WQ2465MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD19, SGN-19A Vector Vector SGN-19A
GTVCR-WQ1212MR IVTScrip™ pT7-VEE-mRNA-Anti-CD19, FMC63 scFv-G4h-28-F9Z-TpERt CAR Vector Vector FMC63 scFv-G4h-28-F9Z-TpERt CAR
GTVCR-WQ393MR IVTScrip™ pSP6-VEE-mRNA-Anti-C5, ALXN-1210 Vector Vector ALXN-1210
GTVCR-WQ343MR IVTScrip™ pT7-VEE-mRNA-Anti-INSR, AGT-181 Vector Vector AGT-181
GTVCR-WQ910MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD2, CD58-Fc Vector Vector CD58-Fc
GTVCR-WQ1546MR IVTScrip™ pSP6-VEE-mRNA-Anti-MS4A1, IMMU-106 Vector Vector IMMU-106
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.